Inhibiting O-GlcNAcylation impacts p38 and Erk1/2 signaling and perturbs cardiomyocyte hypertrophy is a research paper published in Journal of Biological Chemistry (2023). On theSindex it has a DataRank of 0.464. It has been cited 21 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.464
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: T32HL007227
National Institutes of Health
Grant: R01HL139640
National Institutes of Health
Grant: U01CA230978
NHLBI
Grant: R01HL134821
NHLBI
Grant: HL141952
American Heart Association
Grant: 935823
American Heart Association
Grant: 18TPA34170575
NHLBI NIH HHS
Grant: K12 HL141952
Simon Fraser University
FWCI
1.94
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals